Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain
NCT00415597
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
467
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Interventions
DRUG:
ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)
Sponsor
Pfizer